Adverse Event Reporting
| VAERS ID | 1627995 |
|---|---|
| Gender | Male |
| Age | 77 |
| StateCode | TX |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EN6198 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-02-25 |
| Onset | 2021-08-07 |
| Condition | Hospitalized Died |
Symptoms
- Fatigue
- Pyrexia
- Headache
- Chills
- Decreased appetite
- Cough
- Chest X-ray abnormal
- Abdominal pain
- SARS-CoV-2 test positive
- COVID-19
- Pneumonia
- Respiratory distress
- COVID-19 pneumonia
- Respiratory failure
- Death
- Lung opacity
- Thirst decreased
Current Illness
Preexisting Conditions
Hx of malignant skin melanoma, COPD, paroxysmal AFIB, CAD, DM II cont.
Other Medications
asprin 81mg chewable daily, carvedilol 12.5mg BID cont.
Previous Vaccinations
Allergies
NKDA
Laboratory Data
Write-up
Pfizer-BioNTech COVID-19 Vaccine EUA Patient received Pfizer-BioNTech COVID Vaccines on 2/4/2021 and 2/25/2021.
Patient diagnosed with COVID-19 on 8/6/21 presented to ED complaining of worsening repsiratory status over a couple of days.
1 day prior to ED visit pt was given Decadron and discharged from unknown location per provider note.
Associated symptoms include headache, cough, fever (T-max 104°), chills, decreased appetite/thirst, abdominal cramping with cough, and fatigue.
X-ray shows moderate bilateral airspace opacities left greater than right, most consistent with multilevel low-grade pneumonia in this clinical setting.
Pt treated with ceftriaxone, azithromycin x 3days 8/10, solumedrol #4 cont.